Dr Lacombe, Director EORTC Headquarters, talks with ecancer.tv about SPECTA during WIN 2014
8 Jul 2014
Dr Denis Lacombe, Director EORTC Headquarters, spoke with ecancer.tv about the EORTC’s SPECTA, Screening Patients for Efficient Clinical Trial Access, initiative during WIN 2014. He discussed the SPECTA initiative and perspectives for effective cancer drug development.
Watch here the video of the interview
Related News
Final results of ARCAGEN – An EORTC-SPECTA and EURACAN initiative for molecular profiling and access to treatment for rare cancers
23 Jul 2026
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
17 May 2026
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
